Health

Add as a preferred source on Google

Europe’s HPV Vaccination Rates Range From 96% to 3%, ECDC Finds

Portugal leads completion among girls and boys by age 15, while the European Union remains below its 90% target for girls.

Updated 2 min read
Families enter a Lisbon vaccination clinic during an adolescent immunization session. / EconoTimes.ai
Families enter a Lisbon vaccination clinic during an adolescent immunization session. / EconoTimes.ai

Human papillomavirus vaccination completion differs widely across Europe, with Portugal far above the European Union’s target and Bulgaria among the countries furthest behind, new ECDC data show.

The European Centre for Disease Prevention and Control’s 2025 report, using World Health Organization immunization data, measures whether children reaching age 15 received the first and final recommended doses in 2024. Among girls, completion was 96% in Portugal, 86% in Sweden, 85% in Spain, 45% in France, 23% in Romania and 3% in Bulgaria.

Boys’ coverage was also uneven. Portugal recorded 91% completion, followed by Norway at 88% and Sweden at 82%. Italy was at 46%, France at 25% and Slovakia at 11%; the ECDC table listed no completion estimate for boys in Bulgaria or Romania.

The EU has set a goal of at least 90% coverage among eligible girls, along with a significant increase among boys. A 2024 Council recommendation called for vaccination programs covering both sexes and catch-up efforts for people who missed routine doses. ECDC said the recommendation gives it a key role in monitoring HPV vaccination program performance.

Separate OECD figures for 2023 put the EU’s unweighted average for girls receiving all recommended doses by age 15 at 64%. Portugal was at 91% and Bulgaria at 7%, although the OECD and ECDC figures cover different reporting periods.

HPV infections are common and are usually cleared by the immune system. Persistent infection with high-risk types can cause cervical cancer and other cancers, which is why vaccination is most effective before exposure. Coverage is higher among girls because many national programs introduced vaccination for girls first.

A Cochrane review of 225 studies involving more than 132 million people said vaccination was probably associated with roughly an 80% reduction in cervical-cancer incidence when given by age 16. The World Health Organization and the International Agency for Research on Cancer estimated 604,000 new cervical-cancer cases and about 280,000 deaths worldwide in 2024. WHO says unequal access to vaccination, screening and treatment contributes to the disease’s uneven burden; earlier EconoTimes coverage examined cervical-screening gaps.

HPV vaccines have been authorized in the EU since 2006. Santé publique France reported that a school campaign launched in 2023 lifted first-dose coverage among 12-year-olds from 38% to 55% by year-end, reaching 55% among girls and 41% among boys. ECDC’s monitoring role will track how national programs progress toward the EU’s coverage goals.

Related articles

View all